Covered recipient · General Payments record
JUAN A ESTIGARRIBIA
Allopathic & Osteopathic Physicians Internal Medicine Endocrinology, Diabetes & Metabolism
General Payments · PY2018–2024
$3,624.66
- Reported across 217 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $482.93 | 23 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| DEXCOM, INC. | $93.92 | 4 |
| Novo Nordisk AS | $64.27 | 4 |
| Amgen Inc. | $63.60 | 3 |
| Lilly USA, LLC | $56.00 | 3 |
| Xeris Pharmaceuticals, Inc. | $35.88 | 2 |
| Nevro Corp. | $30.56 | 1 |
| Neurocrine BioSciences, Inc. | $28.09 | 1 |
| Tandem Diabetes Care, Inc. | $24.61 | 1 |
| Amneal Pharmaceuticals LLC | $23.49 | 1 |
| RECORDATI_RARE_DISEASES_INC. | $21.79 | 1 |
| CHIESI USA, INC. | $20.48 | 1 |
| Corcept Therapeutics | $20.24 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (23)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $22.38 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111571412 | CMS |
| Amgen Inc. | $21.14 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111571414 | CMS |
| Amgen Inc. | $20.08 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111571416 | CMS |
| Amneal Pharmaceuticals LLC | $23.49 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139185104 | CMS |
| Chiesi USA, Inc. | $20.48 | 07/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151805744 | CMS |
| Corcept Therapeutics | $20.24 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117733300 | CMS |
| Dexcom, Inc. | $16.72 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153311918 | CMS |
| Dexcom, Inc. | $25.83 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153311920 | CMS |
| Dexcom, Inc. | $16.63 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153311922 | CMS |
| Dexcom, Inc. | $34.74 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153311924 | CMS |
| Lilly USA, LLC | $13.57 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135097632 | CMS |
| Lilly USA, LLC | $24.91 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135097634 | CMS |
| Lilly USA, LLC | $17.52 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135074991 | CMS |
| Neurocrine Biosciences, Inc. | $28.09 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150830753 | CMS |
| Nevro Corp. | $30.56 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130729937 | CMS |
| Novo Nordisk Inc | $14.19 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096974331 | CMS |
| Novo Nordisk Inc | $17.27 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097141808 | CMS |
| Novo Nordisk Inc | $16.96 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096725949 | CMS |
| Novo Nordisk Inc | $15.85 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097749014 | CMS |
| RECORDATI_RARE_DISEASES_INC. | $21.79 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139162440 | CMS |
| Tandem Diabetes Care, Inc. | $24.61 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138750959 | CMS |
| Xeris Pharmaceuticals, Inc. | $19.16 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144600496 | CMS |
| Xeris Pharmaceuticals, Inc. | $16.72 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144600498 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.